Sumatriptan Dosing in Adults
For adults with normal renal and hepatic function, the recommended oral dose of sumatriptan is 50 mg or 100 mg at migraine onset, with the 50 mg dose offering the optimal balance of efficacy and tolerability. 1, 2
Oral Dosing
- Start with 50 mg or 100 mg as a single dose at the onset of migraine symptoms 2
- The 50 mg dose provides the best efficacy-to-tolerability ratio, though many patients prefer or require the 100 mg dose 3
- The 25 mg dose is less effective than higher doses and should generally be avoided unless tolerability is a concern 3
- If headache persists or returns after 2 hours, a second dose may be taken with at least 2 hours between doses 2
- Maximum daily dose: 200 mg in 24 hours 1, 2
The 100 mg dose does not provide significantly greater efficacy than 50 mg but carries higher risk of adverse events 1, 3. However, when patients self-select dosing, they tend to migrate toward the 100 mg dose 3.
Alternative Routes of Administration
Subcutaneous administration:
- 6 mg subcutaneously provides the most rapid and effective relief 4, 5
- Can be repeated once after 1-2 hours if needed 5
- Maximum: 12 mg per 24 hours 6, 5
- Achieves pain relief in 70-80% of patients within 1 hour 7, 8
Intranasal administration:
- 20 mg intranasally (single dose in one nostril) 4
- Can be repeated after 2 hours if needed 5
- Maximum: 40 mg per 24 hours 5
- Alternative dosing: 5-10 mg (one to two sprays) 5
Important Dosing Considerations
Timing of administration:
- Taking sumatriptan early when pain is still mild is more effective than waiting until pain becomes moderate or severe 9
- Should not be given during the migraine aura phase 8
Treatment trial:
- Patients should try sumatriptan for 2-3 headache episodes before abandoning therapy, as individual response varies 5, 1
Frequency limitations:
Combination Therapy
- If adequate dose of sumatriptan provides insufficient relief, add an NSAID or acetaminophen rather than increasing sumatriptan dose 5
- This combination approach is recommended by current guidelines when monotherapy fails 5
Hepatic Impairment
- In mild to moderate hepatic impairment, maximum single dose should not exceed 50 mg orally 1, 2
- Hepatic disease can cause unpredictable elevations in oral sumatriptan bioavailability 1
Critical Contraindications
Do not use sumatriptan with:
- MAO inhibitors (contraindicated due to unpredictable bioavailability elevations) 1, 2
- Ergotamine-containing medications within 24 hours 10, 5
- Another triptan within 24 hours 10, 5
Do not use in patients with:
- Ischemic heart disease, previous myocardial infarction, or Prinzmetal angina 8
- Uncontrolled hypertension 10, 8
- Hemiplegic or basilar migraine 10, 5
Common Adverse Effects
- Chest pressure, tightness, or heaviness (3-5% of patients) 4, 10
- Injection site reactions with subcutaneous route (approximately 30%) 5, 8
- Nausea, dizziness, fatigue, and malaise 4, 10
- Most adverse events are mild to moderate, transient, and resolve without intervention 4